Ledger.Open graph →
SEC Form D · filed January 24, 2022

i2O Therapeutics, Inc

Offering
$3.0M
Sold
$2.3M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
SARATOGA, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (14)

Katie Ellias · Saratoga, CADirectorRavi Srinivasan · Saratoga, CAExec · DirectorSamir Mitragotri · Saratoga, CAExec · DirectorChristopher Gagliardi · Saratoga, CADirectorClass VI Capital Partners, LP · STAMFORD, CTExec · DirectorMiguel Forbes · Dumfries, VAExec · DirectorDavid Stonehill · Dumfries, VADirectorMatt Gohd · Dumfries, VADirectorKurt Graves · Saratoga, CADirectorAREX Capital Management, LP · New York, NYExec · DirectorAREX Capital GP, LLC · New York, NYDirectorAndrew J. Phillips · Boulder, CODirectorKarl Anderson · New York, NYExec · DirectorKurt Graves · Saratoga, CADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗